2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 250mg

1-Cycloheptyl-3-mesityl-1H-imidazol-3-ium chloride, 97%, 250mg

(3S,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester, 98+%, 100mg

2-Butylnaphthalene, 95.0%, 5g

2-(METHYLSULFONYL)ETHYL N-SUCCINIMIDYL CARBONATE, 95.0%, 1g

(3-Fluoro-5-methylphenyl)methanamine hydrochloride, 95%, 250mg

3-(DIFLUOROMETHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ANILINE, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-1701, L 25 m, Ø-Innen 0,32 mm, Filmd. 0,50 µm, 1 Stück

3-(Trifluoromethyl)benzaldehyde, 99.0%, 500g

7-Hydroxy-2-methylisoquinolin-1(2H)-one, 98%, 100mg

Methyl 5-amino-1H-imidazole-4-carboxylate, 95.0%, 250mg

2,2'-Bis(2-chlorophenyl)-4,4',5,5'-tetraphenyl-1,1'-biimidazole, 98%, 100g

3-Hydroxypiperidine>98.0%(GC)25g